The Cannabis Market Projected to Benefit from Legalization

Thursday, March 15, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, March 15, 2018 /PRNewswire/ --

According to data published

by Energias Market Research, the global medical cannabis market is expected to grow significantly from USD 8.28 billion in 2017 to USD 28.07 billion in 2024, at a CAGR of 19.1% from 2018 to
2024. Factors driving the growth of the medical cannabis market include growing recognition of medical benefits, increasing demand for cannabis in the treatment of various diseases, and growing number of research and development activities. In the U.S, there are 28 states which have approved the use of cannabis for medical purposes. In major markets like Colorado, California, Alaska, Massachusetts and Nevada, cannabis is legal for recreational use. Global Payout, Inc. (OTC: GOHE), Organigram Holdings Inc. (OTC: OGRMF), Solis Tek Inc. (OTC: SLTK), Future Farm Technologies Inc. (OTC: FFRMF), CannaGrow Holdings, Inc. (OTC: CGRW)

The potential financial benefits from the legalization are important economically and politically. Fortune reported that, "in order to collect $1 billion a year in taxes, the state will need to reach a projected $7 billion in annual legal recreational cannabis sales. At that rate, California would easily be the country's largest legal marijuana market, as the entire legal cannabis industry in the U.S. is expected to pull in roughly $10 billion in total sales for 2017. That number would almost certainly get a boost in the coming years, as legal markets grow in California and other states, such as Nevada and Massachusetts."

Global Payout, Inc. (OTC: GOHE) on March 8th announced breaking news that, "its subsidiary MoneyTrac Technology, Inc. ("MTRAC", the "Company") is launching a Regulation D 506(c) offering that will be centered around the Company's MTRAC-Token™. The Company plans to use this new token to accomplish its goal of "Banking the UnbankableTM". This press release is not being used for the purpose of solicitating the market for any of the securities offered (see disclaimer below).

The launch of the raise and MTRAC-Token is both the culmination of months spent building crucial relationships and marks the beginning of something much larger for the Company. MTRAC views itself as a "New Age Technology Holding Company," through its network of partnerships and affiliate clients, pioneering a course in the cannabis industry into what has been dubbed the "New Gold Rush." As the cannabis industry currently faces the challenges with banking accessibility and electronic payment solution availability, MTRAC intends to utilize this raise as the resource needed to deliver the solutions they have been co-developing to this rapidly growing industry. With this opportunity MTRAC will work to address some of the industry's biggest challenges by facing them head on and introducing "The New Age of Currency"

Said MTRAC CEO, Vanessa Luna: "The MTRAC-Token™ is a unique type of investment opportunity providing investors a way to be involved in revolutionizing a multitude of industries. Our singular focus over the past several months has been meticulously piecing together our powerful network of partners, which combines two of the most influential and newly successful industries of our generation, cannabis and blockchain technology. We at MoneyTrac are a team of innovators working to develop and introduce the solutions necessary to give businesses operating in the legal cannabis sector the specific tools needed to flourish. There has never been a time like the present, when technology and finance converge to create viable, and much needed, solutions in a burgeoning new industry, which is expected to grow exponentially over the next few years. This is the opportunity -- this is The MTRAC-Token™."

Organigram Holdings Inc. (OTCQB: OGRMF) is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the company is regulated by the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). on April 10, 2017, Organigram signed a letter of intent to acquire all of the issued and outstanding shares of Trauma Healing Centers Incorporated ("THC"). THC specializes in medical cannabis assessment and prescribing while offering a multi-disciplinary approach to healing chronic conditions. "The acquisition of THC will allow Organigram to accelerate its patient onboarding strategy and further vertically integrates our goal company's cannabis value chain," says Greg Engel, Chief Executive Officer of Organigram.

Solis Tek Inc. (OTCQB: SLTK), parent company of wholly owned subsidiaries Solis Tek Digital Lighting and Zelda Horticulture, is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and recreational space in legal markets across the U.S. On February 27, 2018, the company announced a cooperative agreement under which Solis Tek will become Medicine Man Technologies' recommended supplier of High Intensity Discharge (HID) lighting technologies for its current and prospective consulting and sales relationships. The recommended status includes Solis Tek Lighting as its specified cultivation lamp fixture in both its equipment lists as well as facility designs. Under the terms of the agreement, Solis Tek will provide Medicine Man with an exclusive pricing list for its lighting products.

Future Farm Technologies Inc. (OTCQX: FFRMF) is a Canadian company with projects throughout North America including California, Florida and Maryland. The Company's business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants, with a focus on cannabis. Recently, the company announced that its Puerto Rico subsidiary has signed the first of five planned leases for its Clinica Verde branded Puerto Rico dispensaries. The Company expects to sign two more leases in the next thirty days with the additional two leases to follow soon after. Future Farm continues to execute on its strategy of building a portfolio of valuable, revenue-generating assets in the fastest growing cannabis and hemp markets in North America.

CannaGrow Holdings, Inc. (OTC: CGRW) has entered the Medical/Recreational Cannabis Industry as a Lessor, Liaison, and Consultant to Licensed Growers, providing them with turnkey Growing Facilities in the State of Colorado. On February 7, 2018, the company announced the Licensed Grower at their Colorado Buffalo Ranch Facility, Category One Botanicals, LLC, has been selected as one of three (3) Independent Organic Farmers to source product for the new Sun Grown Cannabis Line launched this week by the Willie Nelson brand, Willie's Reserve. CannaGrow Holdings and its associate company, Category One Botanicals, LLC, the licensed grower, are dedicated to taking a leading role in the transformation of the legal Cannabis Industry into a vital, responsible sector of the American economy.

Subscribe Now! Watch us report LIVE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For global payout, inc. financial news dissemination and PR services, has been compensated four thousand dollars for financial news dissemination and PR services by cambridge consultants. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: .

For further information: Media Contact: , +1-877-601-1879 URL:


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store